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Abstract
Objective: The aim of this study was to test specific stem cells that could enhance bone formation in combination 
with specific scaffolds.
Methods: Dental Pulp Stem Cells (DPSCs) were seeded with Granular Deproteinized Bovine Bone (GDPB) 
or Beta-Tricalcium Phosphate (ß-TCP) in a rat model of calvarial "critical size" defect. DPSCs were isolated from 
permanent human teeth, obtained and characterized using specific stem cells markers (Nanog and Oct-4) by real 
time-PCR and immunofluorescence. Cells were differentiated for 10-15 days towards the osteoblastic phenotype 
with 100μM L-ascorbic acid, added every day in culture medium and 20 vol. percentage of FBS in α-MEM medium. 
Osteogenic commitment was evaluated with real time-PCR by measuring the expression of specific markers 
(osteonectin and runx2). When a sufficient cell number was obtained, DPSCs were trypsinized, washed in culture 
medium and seeded onto the GDPB and ß-TCP scaffold sat a density of 0.5-1×106 cells/scaffold. Two bilateral 
critical-size circular defects (5 mm diameter; 1 mm thickness) were created from the parietal bone of the 8 athymic 
T-cell deficient nude rats. One cranial defect for each rat was filled with the scaffold alone and the other defect with 
the scaffold seeded with stem cells. After 12 weeks post-surgery animals were euthanized and histomorphometric 
analysis was performed. Differences between groups were analyzed by one-way analysis of variance (ANOVA) 
followed by Fisher's Protected Least Significant Difference (PLSD) post-hoc test. A p-value <0.05 was considered 
statistically significant.
Results: GDPB group presented higher percentage of lamellar bone than that of GDPB/DPSC, ß-TCP alone had 
lower levels as compared to ß-TCP/DPSC. The addition of stem cells significantly increased woven bone formation in 
both scaffold-based implants, although still higher in GDPB based implants. 
Conclusion: Our findings indicate that GDPB and ß-TCP used as scaffold to induce bone regeneration may 
benefit from adding DPSC to tissue-engineered constructs.
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Introduction
Improvement of successful methods for the induction of bone 
regeneration is a significant clinical problem in oral reconstructive 
surgery critical size bony defects, resulting from trauma, chronic 
infection, congenital defects, or surgical resection. Autologous bone 
grafting remains the gold standard for its osteogenic, osteoinductive 
and osteoconductive properties but it has significant drawbacks, 
included limited intraoral supply, an additional operation under 
general anesthesia in case of extraoral donor site,  donor site discomfort 
and morbidity.
In the recent years the use of biomaterials has been adopted to 
guide and favour bone regeneration due to their capability to mimic 
the natural environment of the extracellular matrix [1]. To further 
increase the effectiveness of this methodology, the use of different 
scaffolds in association with stem cells with osteoblast-like activity 
has been introduced [2,3]. Mesenchymal stem cells (MSCs) have been 
proved to be effective with such developed biomaterials, since they are 
capable to induce new bone formation in critical-size defects of animal 
models after differentiation towards osteoblastic phenotype [4-7]. 
In particular, it has been investigated the capacity of inducing bone 
formation of two stem cell populations, dental pulp stem cells (DPSCs) 
[8] and periosteal stem cells (PeSC) [9], seeded with different scaffolds 
in a tissue-engineered construct.
It is now known that in human dental pulp tissue there is a subset 
Citation: Annibali S, Quaranta R, Scarano A, Pilloni A, Cicconetti A, et al. (2016) Histomorphometric Evaluation of Bone Regeneration Induced by 
Biodegradable Scaffolds as Carriers for Dental Pulp Stem Cells in a Rat Model of Calvarial "Critical Size" Defect. J Stem Cell Res Ther 6: 
322. doi:10.4172/2157-7633.1000322
Page 2 of 8
Volume 6 • Issue 1 • 1000322
J Stem Cell Res Ther
ISSN: 2157-7633 JSCRT, an open access journal 
of stem cells, that present mesenchymal characteristics and could be 
directionally differentiated towards various lineages, like adipogenic, 
osteogenic chondrogenic, myogenic and neurogenic ones. DPSCs 
display multifactorial potential such asproliferative capacity, easy 
accessibility, high viability and osteogenic differentiation capacity. 
Furthermore their retrieval is relatively simple and non-invasive, 
no risks for developing immune reactions or rejection following 
transplantation exist and no immunosuppressive therapyis needed [8]. 
In association with appropriated scaffolds DPSCs represent thus an 
ideal stem cell population to build a tissue-engineered construct.
Among the scaffolds utilized in dentistry for bone regeneration, 
Granular Deproteinized Bovine Bone (GDPB) (Geistlich Bio-Oss® 
Collagen, Geistlich Pharma North America, Inc. 202 Carnegie Center, 
Princeton, NJ 08540) and Beta-Tricalcium Phosphate (ß-TCP) 
(SynthograftTM, Bicon Dental Implants, 501 Arborway, Boston, 
MA 02130 USA)  are two of the most widely utilized because of their 
composition, structure, and degradation profile. GDPB is a bone 
substitute of bovine origin made by bone granules supplemented 
with 10% highly purified porcine collagen with a porosity (250-1000 
µm) and crystal size similar to human bone. ß-TCP is a synthetic, 
biocompatible, and resorbable granular ceramic material with a pore 
size of 50-500 µm.
The combination of DPSCs with these scaffolds is therefore an ideal 
combination to generate a valid tissue-engineered construct, which 
can provide useful data on a translational perspective of clinical use in 
scaffold-based bone tissue engineering.
With this in mind, in a first study [10] we found that bone 
regeneration capacity of DPSC or PeSCin SCID BEIGE nude mice, 
measured as a percentage of bone volume of the total defect area, did 
not significantly differ from that induced by the scaffolds alone when 
seeded with two scaffolds commercially available [GDPB [11] and 
(ß-TCP) [12]. Subsequently, we investigated the regeneration capacity 
of two previously tested biomaterials, used alone and in combination 
with DPSC, in nude immunodeficient rats using micro-Computed 
tomography (micro-CT) to evaluate Bone Mineral Density (BMD) 
and Positron Emission Tomography (PET) to analyze the relationship 
between osteoblastic and osteoclastic activities [13]. The results gave 
us valuable information on the positioning of the implanted scaffold 
and the capacity to induce bone formation measured as Bone Mineral 
Density (BMD) or Standard Up-take Value (SUV) of Sodium Fluoride 
Tracer ((18F)-NaF) incorporation. The data showed that GDPB-based 
implant were more precisely positioned, as compared to ß-TCP. 
Moreover, GDPB induced higher BMD and SUV values within the 
cranial defect as compared to ß-TCP, either alone or in combination 
with stem cells. However, the contribution of stem cells to new bone 
formation was unclear, since no significant trend to increase in BMD 
and SUV values as compared to the scaffolds grafted alone was found.
Thus, in this study we characterized bone formation induced into 
the graft by means of histochemical analysis. These data included 
the evaluation of the percentages of residual biomaterial, new bone 
formation and marrow spaces in cranial defects filled with GDPD- 
and ß-TCP-based implants, alone or in combination with DPSC. 
Moreover, qualitative observations with histomorphometry were 
provided, consisting in the determination of bone quality (lamellar 
or woven), the presence of residual biomaterial and inflammatory 
mediators within the defect.
Materials and Methods
Animals 
Athymic T-cell deficient nude rats (n=8) (NIH-RNU FOXN1, 
Charles River Laboratories International, Inc. Wilmington, MA, 
USA), ranging from 12-14 weeks of age, were used in this study. The 
use of such specific strains of rats was decided because they do not 
show immune response because of the necessity of using human stem 
cells for bone regeneration. Rats were kept under standard conditions 
(12/12h dark/light cycle and access to water and food ad libitum). The 
guidelines for ethical conduct (D.Lgs. n.26/2014, in accordance with 
European Directive 2010/63/UE) were followed and all efforts were 
made to minimize animal pain or discomfort.
Scaffolds
GDPB and ß-TCP were utilized to prepare the tissue-engineered 
scaffolds.  The regenerative potential of Geistlich Bio-Oss® Collagen 
distinguishes it clearly from simple collagen sponges, because 90% 
of particles of Geistlich Bio-Oss® serve as a scaffold for new bone 
formation, and 10% collagen of porcine origin makes it malleable and 
easy to handle.
ß-TCP provides for an optimal environment for bone regeneration, 
because both micro-porosity and nano-porosity (pore size of 50-500 
μm) give it a greater surface area compared to other synthetic bone 
grafting materials, and allow for rapid vascularization and subsequent 
resorption. Furthermore, as a pure synthetic material, it does not 
have the inherent risks associated with biologically-derived bone graft 
materials.
Cell culture: characterization and osteogenic differentiation 
of DPSC
Dental pulp stem cells (DPSCs) were isolated from human impacted 
third molars extracted  from adults (19–29 years of age) and cultured 
according to established protocols [14]. Briefly, the pulp tissue was 
gently separated from the crown and root and then digested in a solution 
of 3mg/ml collagenase type I (Gibco®) and 4mg/ml dispase (Gibco®) in 
a Ca2+-Mg2+free phosphate-buffered saline (PBS, EuroClone®) at 37°C 
for 1 hour, in agitation (950rpm) on a docking platform (Eppendorf 
Thermomixer). A single-cell suspension was obtained by passing the 
cells through a 70-μm cell strainer (BD FalconTM) and then the cells 
were seeded into a 60 mm plastic tissue culture dish (BD FalconTM) 
and cultured with α-MEM medium (EuroClone®) supplemented with 
10% fetal bovine serum (FBS, Gibco®), 2% penicillin/streptomycin 
(EuroClone®), and 1% L-glutamine (EuroClone®), then incubated at 
37°C in a humid atmosphere containing 5% CO2. On the following day, 
red blood cells and other non-adherent cells were removed and fresh 
medium was added to favour the growth of adherent stem cells. The cells 
were allowed to reach approximately 80% confluence and were defined 
as passage zero (P0) cells. Later passages were named accordingly. For 
passaging, the cells were washed with PBS and detached by incubating 
with 0.05% trypsin-EDTA 0.02% in PBS solution (EuroClone®) for 
5-10 min at 37°C. Stem cells were replated in a new 100 mm dish with 
an appropriate dilution. Growth medium was replaced every 3 days 
over a 15–20 day period.
Primary cell lines of DPSCs were characterized using specific stem 
cells markers such as Nanog and Oct-4 (POU class 5 homeobox 1) by 
western blot, immunofluorescence, and RT-PCR. The primary antibody 
against Oct-4 and Nanog where purchased respectively from Abcam 
(cat. number ab19857) and Cosmo Bio (cat. number RCAB0002P-F). 
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For RT-PCR, the sense and antisense primers used are adapted from 
[15] and listed in (Table 1). The expression of CD146 was evaluated 
by flow cytometry (FACS Calibur, BD Biosciences) using an α-CD146 
antibody (BD PharmingenTM, cat. number 550315) [16]. The data were 
analyzed with Cell Quest software (BD Biosciences) and the forward 
and side scatter profile gated out debris and dead cells.
According to established protocols [14], differentiated cells towards 
osteoblastic phenotype were obtained by treatment with 100μML-
ascorbic acid (Sigma), added every day in the culture medium, and 
increasing the FBS from 10 to 20% in the α-MEM medium. The cells 
were treated 10-15 days before using them to seed the scaffolds. The 
osteogenic commitment was identified by the expression of specific 
markers, such as osteonectin, and runx2 (runt-related transcription 
factor 2) by RT-PCR. The sense and antisense primers used are adapted 
from [15,16] and listed in Table 1.
Isolation of dental stem cells and in vitro osteogenic 
differentiation.
 The majority of cells displayed a fibroblast-like, spindle-shaped 
morphology as shown in (Figure 1a), and no changes were observed 
throughout the passages. In order to evaluate the undifferentiated state 
of DPSCs isolated, we analyzed the expression of CD146, a known cell 
surface marker identified on mesenchymal stem cells [17], by flow 
cytometry analysis. As reported in (Figure 1b), 91.45% of the cells are 
positive to CD146 respect to the control. To better characterized the 
cells, we analyzed the expression of other markers related staminality, 
like nanog and oct-4, by western blot (Figure 1c), RT-PCR (Figure 1d) 
and immunofluorescence analyses (Figure 1e). 
In order to differentiate the staminal cells towards osteogenic 
phenotype we treated them with 100μM L-ascorbic acid and we added 
a 20% of FBS in the α-MEM medium, since is well-known that FBS 
exerts a differentiation activity favoring osteoblastic differentiation, 
when used in high percentage [18]. mRNA isolated from DPSCs after 
the treatment was used for RT-PCR analysis to evaluated the expression 
of osteogenic markers, like runx2 and osteonectin, as shown in (Figure 
1f). The DPSCs triggered towards osteogenic differentiation were used 
to seed the scaffolds.
Scaffold preparation
When a sufficient cell number was obtained, DPSCs were seeded 
onto the scaffolds. For each sample, a little block, approximately 5×5×1 
mm, of granular deproteinized bovine bone (GDPB, Geistlich Bio-Oss 
Collagen®) was posed in a 24-well plates, while for beta-tricalcium 
phosphate (β-TCP, SynthograftTM) an amount of granulate was 
distributed in each well of a 96-well plate. Both of them were pre-wetted 
before adding the cells through an incubation in culture medium at 
37°C for 1h. The differentiated cells, after the treatment with 20 vol.% 
of FBS and 100 μM L-ascorbic acid, were trypsinized, then washed in 
culture medium and seeded on the scaffolds at a density of 0,5-1×106 
cells/scaffold. The amount of cells needed were centrifuged and then 
resuspended in a little amount of culture medium in order to gently 
plate them on the scaffold with a micropipette. For the GDPB alone, 
the scaffold was transfer in a new well before adding the cells and, 
after 1 hour, 1 ml of medium was added to the well with GDPB plus 
DPSC. The in vitro cell constructs were cultured in osteogenic inducing 
medium for 2 days in a humidified atmosphere at 37°C containing 5% 
CO2.
In vivo cranial defect
Two bilateral critical-size circular defects (5 mm diameter, 1-mm 
thickness) were created on either side of the sagittal suture line in the 
parietal bone soft the rat skull, using a hand drill and trephine, under 
sterile saline to protect the brain from heating. During the procedure, 
care was taken to avoid damages to the sagittal suture and to the dura 
mater. Surgery was performed under general anesthesiaby 0.3 cc- 0.5 
cc intraperitoneal injection of Ketamine (100 mg/ml)+Xylazine (20 
mg/ml) +  Acepromazine  (10 mg/ml) mixed in 2:1 sterile saline. 
Ketoprofen (5 mg/kg) was used preoperative for preemptive analgesia 
and postoperative every 12-24 hrs. In addition, the animals were given 
one intraperitoneal injection of 70 mg of streptomycin to prevent 
infection.
Experimental groups 
The animals were divided into two experimental groups (n=4 
animals/group): (1) scaffolds seeded with stem cells (0.5-1×106 
DPSC); (2) scaffold without cells. In each rat, one cranial defect 
was filled with the scaffold alone and the other defect with the 
scaffold seeded with stem cells. Thus, four experimental groups 
were generated by combining scaffolds and stem cells: ß-TCP (ß); 
ß-TCP/DPSC(ß/C); GDPB (G) and GDPB/DPSC(G/C). After 12 
weeks post-surgery animals were euthanized with an anaesthetic 
overdose by intraperitoneal injection of 3% pentobarbital sodium 
and histological analysis was performed.
Histological analysis
The specimens were washed in saline solution and immediately 
fixed in 4% para-formaldehyde and 0.1% glutaraldehyde in 0.15 M 
cacodylate buffer at 4°C and pH 7.4, to be processed for histology.
The samples were fixate in PFA for three days. The specimens 
were processed to obtain thin ground sections with the Precise 
1 Automated System (Assing, Rome, Italy). The specimens were 
Genes Forward primer (F)Reverse primer (R)
Gene Bank
accession no.
Size of PCR
product (bp)
Annealing
temperature (ºC)
NANOG
F: CCTCTTAAATTTTTTCCTCCTCTTC
R: AAGTGGGTTGTTTGCCTTTG NM_024865 271 54
Oct-4 (Pou5f1; POU class
5 homeobox 1)
F: TGCCGTGAAACTGAAGAAG
R: TTTCTGCAGAGCTTTGATGTTC NM_203289 72 53
Osteonectin F: TCTTCCCTGTACACTGGCAGTTCR: AGCTCGGTGTGGGAGAGGTA NM_003118 73 55
Runx2 (runt-related
transcription factor 2)
F: CAGACCAGCAGCACTCCATA
R: CAGCGTCAACACCATCATTC NM_004348 178 57
β-actin F: CTACAATGAGCTGCGTGTGGR: CGGTGAGGATCTTCATGAGG NM_001101 314 60
Table 1: RT-PCR primers used in this study.
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video camera (3CCD, JVC KY-F55B, JVC®, Santa Clara, CA, USA) 
and interfaced to a monitor and PC (Intel Pentium III 1200 MMX, 
Intel®, Yokohama, Japan). This optical system was associated with a 
digitizing pad (Matrix Vision GmbH, Oppenweiler, Germany) and a 
histometry software package with image capturing capabilities (Image-
Pro Plus 4.5, Media Cybernetics Inc., Immagini and Computer Snc 
Milan, Italy). Evaluation of the percentages of residual biomaterial, 
new bone formation and marrow spaces was performed in the cranial 
defects of the four experimental groups. Each section was examined 
at a minimum of 6x magnification, and the entire area of the section 
was evaluated. Digital images of each section were acquired and used 
to trace the areas identified as new bone, residual particle and marrow 
spaces.  Image manipulation software was used to create individual 
layers of new bone, residual particle and marrow spaces. These layers 
dehydrated in an ascending series of alcohol rinses and embedded in 
a glycolmethacrylate resin (Technovit 7200 VLC, Kulzer, Wehrheim, 
Germany). After polymerization the specimens were sectioned in the 
mesio-distal direction, with a high-precision diamond disc at about 
150 µm and grounded down to about 30 µm with a specifically designed 
grinding machine. A total of 2 slides were obtained for each specimen. 
For general morphologic observations, sections were stained with acid 
fuchsin and toluidine blue and observed under light microscopy with 
a Leitz Laborlux (Leitz, Wetzlar, Germany), in order to determine the 
relative distribution of new bone matrix and absence of dentine. The 
polarized light were used for distinguish lamellar bone and woven 
bone.
Histomorphometry was carried out using a light microscope 
(Laborlux S, Leitz, Wetzlar, Germany) connected to a high resolution 
Figure 1: a) bright-field image showing the morphology of DPSCs isolated from permanent human teeth dental pulp; b) flow cytometry analysis of cell-surface 
markers in DPSCs. Cells were labelled with CD146 or immunoglobulin isotype antibodies: the graph on the left shows the percentage of positive cells for CD146, 
on the right is evidenced the expression of CD146 (green line) respect to control; c)Nanog and Oct-4 expression in DPSCs was determined in whole-cell extract by 
immunoblot analysis using specific antibodies; d) expression of transcript for nanog and oct-4 genes by RT-PCR. Internal control: β-actin. Negative control: water; 
e) immunofluorescence staining for Nanog (green) and Oct-4 (green) in DPSCs. Nuclei were labelled with DAPI (blue). Magnification:×40; f) expression of transcript 
for runx2 and osteonectin genes by RT-PCR. Internal control: β-actin. Negative control: water. DPSC: dental pulp stem cells; WB: western blot; ctr-: negative control.
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were then converted to a binary (black and white) form, and area by 
percentage of each of the three layers was digitally calculated based on 
number of pixels using image analysis software.
Statistical analysis
Differences between groups of treatment were analyzed by one-
way analysis of variance (ANOVA) followed by Fisher's Protected 
Least Significant Difference (PLSD) post-hoc test. A p-value <0.05 was 
considered statistically significant. Statistical analysis was performed 
using the Stat view software from SAS Institute.
Results
Percentage of residual biomaterial in cranial defects
Figure 1 shows the percentage of residual biomaterial in the cranial 
defects in the four experimental groups. One-way ANOVA showed 
no significant differences among groups. However, we observed that 
GDPC alone has higher percentage of residual biomaterial than ß-TCP 
(Figure 2).
Percentage of new bone formation in cranial defects
The percentage of total bone formation is showed in (Table 
2). One-way ANOVA showed a significant effect of the treatment 
(f-value=4.168; p-value<0.05). Post-hoc analysis showed that the 
percentage of total bone in ß-TCP group was lower than that of ß-TCP/
DPSC (p<0.01), GDPB (p<0.01), and GDPB/DPSC (p<0.05). No other 
statistical differences were observed.
The percentages of new lamellar and woven bone was also measured 
in the four experimental groups and the results are shown in (Figure 
3). One-way ANOVA showed a significant effect of the treatment on 
the formation of lamellar bone (f-value=9.305; p-value<0.01). Post-hoc 
analysis showed that the percentage of lamellar bone in GDPB group 
was higher than that of GDPB/DPSC (p<0.05) and ß-TCP (p<0.001). 
Moreover, the percentage of lamellar bone in ß-TCP/DPSC was 
significantly higher than that of ß-TCP alone(p<0.001) and GDPB/
DPSC(p<0.05).
We also found an effect on woven bone formation (f-value=10.494; 
p-value<0.01). However, the results were different to those of lamellar 
bone. We observed that the percentage of woven bone in GDPB group 
was lower than that of GDPB/DPSC (p<0.05) and higher than that of 
ß-TCP (p<0.05). Furthermore, GDPB/DPSC group showed higher 
percentage of woven bone as compared to ß-TCP (p<0.001) and 
ß-TCP/DPSC (p<0.05) (Figure 3). As for ß-TCP, we found that ß-TCP/
DPSC showed higher percentage of woven formations as compared to 
ß-TCP alone (p<0.05).
Percentage of marrow spaces in cranial defects
The percentages of marrow spaces in the cranial defects in the four 
experimental groups are shown in Figure 4. Also in this case one-way 
ANOVA showed an overall effect of the treatment (f-value=5.007; 
p-value<0.05). Post-hocs revealed that ß-TCP had higher percentage 
of marrow spaces as compared to GDPB (p<0.01), GDPB/DPSC 
(p<0.01) and ß-TCP/DPSC (p<0.05). No other statistical differences 
were observed. 
Qualitative observations on histomorphometry
ß-TCP: In general, bone morphology presented differentiated 
cellular lines specific of mineralized bone, such as osteoblasts, osteocytes 
but also osteoid and blood vessels. An initial formation of immature 
bone extending from the periphery of the bone cavities could be seen 
(Figure 5a,b). The rest of the bone cavity contained fibrous tissue and 
biomaterial with a mild inflammatory reaction. The inflammatory 
reaction was characterized by foci of lymphocytes distributed around 
the periphery of the cavity (Figure 5b). The tissues present in the defect 
were composed by 24 ± 3% of ß-TCP particles, 6 ± 2% of lamellar bone, 
8 ± 1 of woven bone and 59 ± 3% of marrow spaces. 
ß-TCP/DPSC: Bone tissue was evident with well differentiated 
cells and mineralized matrix: osteoid, osteoblasts, osteocytes and blood 
vessels. Regenerating osseous tissue surrounding some ß-TCP particles 
and extending from the margin of the axial walls was observed. Bone 
tissue was positioned in the inter-particular (Figure 6a). New bone 
extended to the basal third from the margin of the bone defect and 
Figure 2: Percentage of residual biomaterial in the cranial defects of the four 
experimental groups: ß-TCP (ß); ß-TCP/DPSC(ß/C); GDPB(G) and GDPB 
/DPSC(G/C). Values are expressed as a percentage of biomaterial on the 
total area of the defect. Data represent means ± SEM. ß-TCP: Beta-tricalcium 
phosphate; GDPB: Granular deproteinized bovine bone; DPSC: Dental pulp 
stem cells.
Figure 3: Percentage of new bone (mature and immature) formation in 
the cranial defects of the four experimental groups: ß-TCP (ß); ß-TCP/
DPSC (ß/C); GDPB(G) and GDPB /DPSC(G/C). Values are expressed as 
a percentage of new bone formation on the total area of the defect. Data 
represent means ± SEM.  Asterisks indicate significant differences between 
time groups (*p < 0.05; ***p<0.001). ß-TCP: Beta-tricalcium phosphate; 
GDPB: Granular deproteinized bovine bone; DPSC: Dental pulp stem cells.
Experimental groups New bone formation (%)
GDPB (G) 23.375 ± 12.3
GDPB/DPSC(G/C) 18.25 ± 9.22
ß-TCP (ß) 8.0 ± 3.46
ß-TCP/DPSC(ß/C) 22.375 ± 11.4*
Data represent means ± SEM. ß-TCP: Beta-tricalcium phosphate; GDPB: 
Granular deproteinized bovine bone; DPSC: dental pulp stem cells 
* statistically significant vs ß-TCP (ß) (p<0.01)
Table 2: Percentage of total bone (lamellar and woven) formation.
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partially surrounded the ß-TCP particles. New bone extended also in 
central part of the bone defects (Figure 6b). Fibrous tissue still occupied 
little space in the defect area. Traces of new bone from the periosteum 
were observed, overlying the superficial portion of the bone defect. No 
dentinal tubules were visible. The tissues present in the  defect were 
composed by 28 ± 3% of ß-TCP/DPSC particles,  32 ± 2% of lamellar 
bone, 12 ± 1 of woven bone and  26 ± 4% of marrow spaces.
GDPB: Little osteoid matrix was present at the periphery of the 
bone defects and osteoblasts were observed. Trabecular bone was 
present in the central portion of the defects (Figure 7a). Particles of 
biomaterial were mostly surrounded by mature bone and fibrous tissue 
(Figure 7b). Bone formation was observed at both margins of the 
defect.Few osteoblasts were present. The tissues present in the defect 
area were composed by 28 ± 4% of GDPB particles, 12 ± 2% of lamellar 
bone, 18 ± 2 of woven bone and 28 ± 4% of marrow spaces. 
GDPB/DPSC: At low magnification, we observed that almost 
all biomaterial particles were surrounded by mature bone. Osteoid 
material was found only around some of the particles (Figure 8a). The 
particles of material were located near the marrow spaces in only a few 
areas (Figure 8b). In all specimens no inflammatory cell infiltrate was 
present. No foreign body reactions were present. All particles were 
clustered and surrounded by newly-formed woven or lamellar bone. 
Newly-formed bone was always present between the GDPB particles. 
No epithelial cells or connective tissue were found at the interface. 
The regenerated bone tissue extended to approximately two-thirds 
of the bone defect apart from the central and superficial area, where 
the fibrous tissue still occupied part of the spaces between granules. 
Prominent lamination of mature bone was observed. Mature bone 
derived from the endosteal surface filled the external portion of the 
bone defects (Figure 8b). The periphery and central portion of the 
cavity showed mineralized new bone formation. No dentinal tubules or 
predentin were visible. The bone defect was not completely healed and 
many particles or GDPB were visible. The tissues present in the defect 
Figure 4: Percentage of marrow space in the cranial defects of the four 
experimental groups: ß-TCP (ß); ß-TCP/DPSC (ß/C); GDPB(G) and GDPB/
DPSC(G/C). Values are expressed as a percentage of marrow space on the 
total area of the defect. Data represent means ± SEM. Asterisks indicate 
significant differences between time groups (*p<0.05; **p<0.01). ß-TCP: 
Beta-tricalcium phosphate; GDPB: Granular deproteinized bovine bone; 
DPSC: Dental pulp stem cells.
Figure 5: a) no trabecular bone was present in the central portion of the bone 
defects (C). New bone extended to the basal third from the margin of the bone 
defect and partially surrounded the S particles (Arrows). Acid fuchsin and 
toluidine blue 2X, Scale bar=1mm; b) previous image at higher magnification. 
Traces of new bone (NB) from the periosteum were seen overlying the 
superficial portion of the bone defect. Osteoblasts,(black arrows) osteocytes 
but also osteoid (M), and blood vessels were observed. Fibrous tissue (F), 
inflammatory cells (I), Biomaterial (ß-TCP). Acid fuchsin and toluidine blue 
100X.
Figure 6: a) new  bone was observed surrounding some  particles (NB). 
Bone formation was observed at both margins of the defect, and this was 
more evident at one of the margins. Acid fuchsin and toluidine blue 2X,Scale 
bar=1mm; b) previous image at higher magnification. New bone (NB) 
surrounded the biomaterial particles (ß-TCP). New bone extended also in 
central part of the bone defects. Fibrous tissue and biomaterial with a mild 
multinucleated cells reaction (arrows). Acid fuchsin and toluidine blue 100X.
Figure 7: a) the biomaterial particles were mostly surrounded by fibrous 
tissue. No new bone was present in the central portion of the bone defects. 
Acid fuchsin and toluidine blue 2X, Scale bar=1mm; b) previous image at 
higher magnification. New bone (Arrows) was present in the periferical portion 
of the bone defects and around biomaterial particles (GDPB). Acid fuchsin 
and toluidine blue 100X.
Figure 8: a) new bone (NB) was observed surrounding some  particles 
and extended also in central part of the bone defects. Bone formation was 
observed at both margins of the defect, and this was more evident at one of 
the margins. Acid fuchsin and toluidine blue 2X, Scale bar=1mm; b) previous 
image at higher magnification. New bone (NB) surrounded the biomaterial 
particles (GDPB). The particles were distributed along the defect and were 
surrounded by new bone (NB). Acid fuchsin and toluidine blue 100X.
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were composed by 31 ± 4% of GDPB particles, 36 ± 2% of lamellar 
bone, 14 ± 1 of woven bone and 18 ± 2% of marrow spaces. 
Discussion
In a previous study we examined bone regeneration induced by 
dental pulp stem cells (DPSCs) in combination with appropriated 
scaffolds (ß-TCP and GDPB) in a rat model of calvarial critical defect by 
using μ- CT and PET analytical methods [13]. In that study we observed 
that GDPB implants were mostly well positioned and induced a higher 
amount of BMD and SUV within the cranial defect as compared to 
ß-TCP. However, the contribution of DPSCs to bone formation in both 
ß-TCP and GDPB-based implants was not clear. Thus, in this study 
we aimed at further characterize bone regeneration induced by DPSCs 
in these scaffold-based implants by using histological parameters. We 
evaluated the percentages of residual biomaterial, new bone formation 
and marrow space in the cranial defects filled with GDPD- and ß-TCP-
based implants, alone or in combination with DPSC. Moreover, a 
qualitative description of the histomorphology of the cranial defect 
was provided, including the characterization of newly-formed bone, 
presence ofinflammatory cells infiltrate, and the position of bone 
formation within the defect.
The results showed that although the percentage of residual 
biomaterial was similar among experimental groups, the percentage of 
formation of new bone and marrow space was different. Specifically, 
we found that, although the percentage of lamellar bone in GDPB 
group was higher than that of ß-TCP, the two scaffolds showed 
different results when seeded with stem cells. Thus, while GDPB group 
had higher percentage of lamellar bone than that of GDPB/DPSC, 
ß-TCP alone had lower levels as compared to ß-TCP/DPSC. When 
analyzing the woven bone, we found instead that addition of stem cells 
significantly increased bone formation in both scaffold-based implants, 
although still higher in GDPB based implants. Another result was 
that the percentage of marrow spaces was higher in ß-TCP group as 
compared to the other groups.
The present findings, when compared to the data obtained 
with μ- CT and PET, show that the positive role of GDPD to bone 
regeneration is due to the formation of mature (lamellar) bone. 
Moreover, the contribution of stem cells was evident when analyzing 
the percentage of woven bone, a finding not shown from the previous 
μ- CT and PET data. These results confirm previous observations on 
the comparison between these two scaffolds. Although both of them 
possess osteoconductive properties and are capable to provide a three-
dimensional structure for bone regeneration [19-22], the use of GDPB 
seems to induce a greater percentage of bone formation. GDPB is a 
biomaterial of natural origin obtained by the deproteinization of bovine 
bone [23,24] while ß-TCP is a synthetic bone substitute resembling 
natural bone in mineral composition [25]. The main difference between 
the two scaffold is that GDPB has lower level of resorption [22,24] as 
compared to ß-TCP [26] and this property may favor bone formation 
in the microenvironment of the calvarial defect. However, the present 
data also suggest that ß-TCP may be more efficient when seeded with 
stem cells as both lamellar and woven bone were increased in the 
ß-TCP/DPSC construct to a level comparable to that of GDPB. Thus, 
it may be speculated that low resorbability of GDPB may favor the 
natural process of bone formation, while the high level of resorption of 
ß-TCP may provide a microenvironment where stem cells are capable 
to produce osteogenic activity with less interference generated by the 
interaction with the scaffold, at least in this model. This hypothesis 
is also confirmed by data showing that ß-TCP may show greater 
osteoconductive and biodegradation properties than GDPB in a rat 
critical-size defect [13] and by the fact that ß-TCP alone has a greater 
percentage of marrow space as compared to GDPB.
Qualitative histomorphometry also showed that addition of stem 
cells to the scaffolds resulted in greater bone formation in ß-TCP/DPSC 
construct, as evidenced by the presence of bone tissue in the periphery 
and in the central area of the defect. Most notably, osteogenesis was 
observed in absence of inflammatory processes which may interfere 
with the process of regeneration [27]. GDPB scaffolds were also 
characterized by the presence of bone formation and absence of 
inflammatory cells infiltrates. However, GDPB alone was characterized 
by the presence of mature rather than immature bone surrounding the 
particles of biomaterial. This finding suggests that, although GDPB 
seems capable to induce greater bone formation as compared to ß-TCP 
alone, this process is likely to terminate earlier as compared to that 
induced by the addition of DPSC into the construct. Nonetheless, 
given the low number of animals used in the study, other studies are 
necessary to validate this hypothesis.
There are some limitation to our data interpretation. Particularly, 
these data are not in line with the findings reported using other 
analytical methods such as μ- CT and PET. The reason for this 
discrepancy is difficult to explain. Certainly, the different analytical 
methods may have influenced the data. In the first study we analyzed 
bone mineral density (BMD) or standard uptake value (SUV) of sodium 
fluoride tracer ([18F]-NaF) incorporation which gave us information 
on the whole process of bone formation. In this study histology was 
used instead to differentiate the bone formation between lamellar and 
woven bone. Thus, it is possible that the difference noted here between 
the scaffold used alone versus the scaffold seeded with stem cells 
would not be detectable with μ- CT and PET methods. On the other 
hand, it should be noted that μ- CT and PET methods provide three 
dimensional data on bone formation while histology can only analyze 
a section at a two-dimensional level. These different findings suggest 
that the contribution of stem cells in these types of constructs may be 
present but only evident on a qualitative level. If the higher percentage 
of immature bone observed in scaffolds seeded with stem cells is then 
translated in a superior capacity of inducing bone formation in the 
clinical practice remains to be determined. Thus, it is advisable that 
other studies with different combinations of stem cells and scaffolds 
should be carried out in order to obtain more consisting data between 
histological and µCt data.
Conclusion
This study demonstrates that addition of stem cells significantly 
increased woven bone formation in both scaffold-based implants. 
Moreover, these data suggest that in absence of stem cells GDPB, 
given its natural origin and higher biocompatibility, induces faster 
and greater lamellar bone formation as compared to that induced by 
ß-TCP.
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